- Home
- TRVI vs LPA Comparison
TRVI vs LPA Comparison
Compare TRVI & LPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- LPA
- Stock Information
- Founded
- TRVI 2011
- LPA 2013
- Country
- TRVI United States
- LPA United States
- Employees
- TRVI N/A
- LPA N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- LPA
- Sector
- TRVI Health Care
- LPA
- Exchange
- TRVI Nasdaq
- LPA Nasdaq
- Market Cap
- TRVI 383.4M
- LPA 310.7M
- IPO Year
- TRVI 2019
- LPA N/A
- Fundamental
- Price
- TRVI $6.07
- LPA $6.80
- Analyst Decision
- TRVI Strong Buy
- LPA
- Analyst Count
- TRVI 8
- LPA 0
- Target Price
- TRVI $17.56
- LPA N/A
- AVG Volume (30 Days)
- TRVI 1.6M
- LPA 17.2K
- Earning Date
- TRVI 05-06-2025
- LPA 05-14-2025
- Dividend Yield
- TRVI N/A
- LPA N/A
- EPS Growth
- TRVI N/A
- LPA N/A
- EPS
- TRVI N/A
- LPA N/A
- Revenue
- TRVI N/A
- LPA $43,862,372.00
- Revenue This Year
- TRVI N/A
- LPA N/A
- Revenue Next Year
- TRVI N/A
- LPA N/A
- P/E Ratio
- TRVI N/A
- LPA N/A
- Revenue Growth
- TRVI N/A
- LPA 11.22
- 52 Week Low
- TRVI $2.30
- LPA $6.00
- 52 Week High
- TRVI $7.39
- LPA $525.00
- Technical
- Relative Strength Index (RSI)
- TRVI 54.54
- LPA N/A
- Support Level
- TRVI $4.85
- LPA N/A
- Resistance Level
- TRVI $6.15
- LPA N/A
- Average True Range (ATR)
- TRVI 0.50
- LPA 0.00
- MACD
- TRVI -0.04
- LPA 0.00
- Stochastic Oscillator
- TRVI 73.94
- LPA 0.00
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About LPA Logistic Properties of the Americas
Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns and manages a diversified portfolio of warehouse logistics assets in Central America and the South America. It focuses on modern Class A logistics real estate in high growth and high barrier-to-entry markets that are undersupplied and have low penetration rates.